HCA Healthcare (NYSE:HCA - Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Tuesday, October 27th. Analysts expect HCA Healthcare to post earnings of $6.66 per share and revenue of $19.33 billion for the quarter. Parties may visit the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 10:00 AM ET.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the firm posted $6.84 earnings per share. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $29.45 EPS for the current fiscal year and $32.05 EPS for the next fiscal year.
HCA Healthcare Stock Performance
HCA opened at $455.53 on Tuesday. The company has a market capitalization of $98.62 billion, a PE ratio of 15.25, a P/E/G ratio of 1.55 and a beta of 1.10. The stock's fifty day moving average is $427.22 and its 200-day moving average is $418.81. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52.
HCA Healthcare Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research report on Monday, July 27th. Leerink Partners reaffirmed an "outperform" rating and issued a $492.00 price objective on shares of HCA Healthcare in a research note on Friday, September 18th. UBS Group dropped their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Finally, TD Cowen increased their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the company a "buy" rating in a research note on Monday, October 12th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $467.61.
View Our Latest Report on HCA
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.